Brief: Kenneth Griffin Reports 5.3% Passive Stake In Terns Pharmaceuticals As Of July 10
July 22 (Reuters) -
Kenneth Griffin:
* KENNETH GRIFFIN REPORTS 5.3% PASSIVE STAKE IN TERNS
PHARMACEUTICALS AS OF JULY 10 - SEC FILING
Source text for Eikon: ID:n0001104659-24-081507
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Terns Pharmaceuticals
See all newsNASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
U.S. RESEARCH ROUNDUP-East West Bancorp, Reliance, S&P Global
Brief: Merck Announces Expiration Of Hart-Scott-Rodino Act Waiting Period To Acquire Terns Pharmaceuticals
Brief: Merck Begins Tender Offer To Acquire Terns Pharmaceuticals, Inc.